These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 10447951)

  • 21. Evolution of phenylalanyl-tRNA synthetase by domain losing.
    Lin J; Huang JF
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Dec; 35(12):1061-5. PubMed ID: 14673495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Large-scale movement of functional domains facilitates aminoacylation by human mitochondrial phenylalanyl-tRNA synthetase.
    Yadavalli SS; Klipcan L; Zozulya A; Banerjee R; Svergun D; Safro M; Ibba M
    FEBS Lett; 2009 Oct; 583(19):3204-8. PubMed ID: 19737557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toxicity of ochratoxin A, its opened lactone form and several of its analogs: structure-activity relationships.
    Xiao H; Madhyastha S; Marquardt RR; Li S; Vodela JK; Frohlich AA; Kemppainen BW
    Toxicol Appl Pharmacol; 1996 Apr; 137(2):182-92. PubMed ID: 8661343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxidation alters the architecture of the phenylalanyl-tRNA synthetase editing domain to confer hyperaccuracy.
    Srinivas P; Steiner RE; Pavelich IJ; Guerrero-Ferreira R; Juneja P; Ibba M; Dunham CM
    Nucleic Acids Res; 2021 Nov; 49(20):11800-11809. PubMed ID: 34581811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chaperone-like activity of mammalian elongation factor eEF1A: renaturation of aminoacyl-tRNA synthetases.
    Lukash TO; Turkivska HV; Negrutskii BS; El'skaya AV
    Int J Biochem Cell Biol; 2004 Jul; 36(7):1341-7. PubMed ID: 15109577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cloning and expression of human phenylalanyl-tRNA synthetase in Escherichia coli: comparative study of purified recombinant enzymes.
    Moor N; Linshiz G; Safro M
    Protein Expr Purif; 2002 Mar; 24(2):260-7. PubMed ID: 11858721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ochratoxins: Molecular strategies for developing an antidote.
    McMasters DR; Vedani A
    ALTEX; 1998; 15(4):218-221. PubMed ID: 11178522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Computational studies of tryptophanyl-tRNA synthetase: activation of ATP by induced-fit.
    Kapustina M; Carter CW
    J Mol Biol; 2006 Oct; 362(5):1159-80. PubMed ID: 16949606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phenylalanyl tRNA synthetase (PheRS) substrate mimics: design, synthesis, molecular dynamics and antimicrobial evaluation.
    Noureldin NA; Richards J; Kothayer H; Baraka MM; Eladl SM; Wootton M; Simons C
    RSC Adv; 2022 Jan; 12(4):2511-2524. PubMed ID: 35425259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of a novel auxiliary pocket in bacterial phenylalanyl-tRNA synthetase druggability.
    Abibi A; Ferguson AD; Fleming PR; Gao N; Hajec LI; Hu J; Laganas VA; McKinney DC; McLeod SM; Prince DB; Shapiro AB; Buurman ET
    J Biol Chem; 2014 Aug; 289(31):21651-62. PubMed ID: 24936059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. α-Phenylalanyl tRNA synthetase competes with Notch signaling through its N-terminal domain.
    Ho MT; Lu J; Vazquez-Pianzola P; Suter B
    PLoS Genet; 2022 Apr; 18(4):e1010185. PubMed ID: 35486661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Target proteins and mechanisms of ochratoxin toxicity. A contribution to the identification of potential ochratoxin antagonists.
    Vedani A; Zbinden P
    ALTEX; 1997; 14(4):155-164. PubMed ID: 11178501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Re-discovery of PF-3845 as a new chemical scaffold inhibiting phenylalanyl-tRNA synthetase in
    Wang H; Xu M; Engelhart CA; Zhang X; Yan B; Pan M; Xu Y; Fan S; Liu R; Xu L; Hua L; Schnappinger D; Chen S
    J Biol Chem; 2021 Jan; ():. PubMed ID: 33397709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Flavonoid aglycones can compete with Ochratoxin A for human serum albumin: a new possible mode of action.
    Poór M; Kunsági-Máté S; Bencsik T; Petrik J; Vladimir-Knežević S; Kőszegi T
    Int J Biol Macromol; 2012 Oct; 51(3):279-83. PubMed ID: 22634515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High Throughput Screen Identifies Natural Product Inhibitor of Phenylalanyl-tRNA Synthetase from Pseudomonas aeruginosa and Streptococcus pneumoniae.
    Hu Y; Palmer SO; Munoz H; Bullard JM
    Curr Drug Discov Technol; 2014; 11(4):279-92. PubMed ID: 25601215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of high affinity fatty acid binding sites on human serum albumin by MM-PBSA method.
    Fujiwara S; Amisaki T
    Biophys J; 2008 Jan; 94(1):95-103. PubMed ID: 17827235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Location of high and low affinity fatty acid binding sites on human serum albumin revealed by NMR drug-competition analysis.
    Simard JR; Zunszain PA; Hamilton JA; Curry S
    J Mol Biol; 2006 Aug; 361(2):336-51. PubMed ID: 16844140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Preventive action of phenylalanine on acute intoxication of ochratoxin-A].
    Creppy E; Schlegel M; Röschenthaler R; Dirheimer G
    C R Seances Acad Sci D; 1979 Nov; 289(13):915-8. PubMed ID: 121251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recognition of non-alpha-amino substrates by pyrrolysyl-tRNA synthetase.
    Kobayashi T; Yanagisawa T; Sakamoto K; Yokoyama S
    J Mol Biol; 2009 Feb; 385(5):1352-60. PubMed ID: 19100747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A series of spirocyclic analogues as potent inhibitors of bacterial phenylalanyl-tRNA synthetases.
    Yu XY; Finn J; Hill JM; Wang ZG; Keith D; Silverman J; Oliver N
    Bioorg Med Chem Lett; 2004 Mar; 14(5):1339-42. PubMed ID: 14980694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.